London
· Delayed Price · Currency is GBP · Price in GBXConvaTec Group Company Description
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally.
The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.
It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.
In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings.
Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson’s disease.
The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers.
It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
| Country | United Kingdom |
| Founded | 1978 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 10,136 |
| CEO | Karim Bitar |
Contact Details
Address: 20 Eastbourne Terrace London, W2 6LG United Kingdom | |
| Phone | 44 11 8952 8100 |
| Website | convatecgroup.com |
Stock Details
| Ticker Symbol | CTEC |
| Exchange | London Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | GB00BD3VFW73 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Karim Bitar | Chief Executive Officer and Director |
| Jonathan Peter Mason | Group Chief Financial Officer and Director |
| John Haller | Executive Vice President and Chief Quality and Operations Officer |
| Dr. Divakar Ramakrishnan Ph.D. | Executive Vice President, Chief Technology Officer and Head of Research and Development |
| Kate Postans | Vice President of Investor Relations and Corporate Communications |
| Evelyn Douglas J.D. | Executive Vice President, Chief of Corporate Strategy and Business Development and General Counsel |
| Moyra Withycombe | Interim Chief People Officer |
| Kjersti Grimsrud Biotechnology, M.Sc. | President and Chief Operating Officer of Infusion Care |
| David Shepherd | President and Chief Operating Officer of Global Advanced Wound Care |
| Seth R. Segel | President and Chief Operating Officer of Continence Care and Home Services Group |